Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Drospirenone 3 mg + Ethinylestradiol 0.02 mg Tablet
Therapeutic Category
Gynecology and Fertility, Endocrinology, ENDOCRINOLOGY and Hormonal range
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10x1x21
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
This tablet combines Drospirenone (3 mg), a progestin, and Ethinylestradiol (0.02 mg), a synthetic estrogen, to form a low-dose oral contraceptive. It works by preventing ovulation, altering the cervical mucus to block sperm entry, and changing the endometrial lining to prevent implantation. Beyond contraception, this combination also helps regulate menstrual cycles, reduce menstrual cramps, treat acne, and manage premenstrual symptoms.
Mild side effects may include nausea, headache, breast tenderness, mood changes, or weight fluctuation. Rare but serious effects include blood clots, hypertension, or liver issues. Regular monitoring is advised for long-term users.
Primarily indicated for oral contraception to prevent pregnancy. It is also used in the treatment of acne vulgaris, premenstrual dysphoric disorder (PMDD), menstrual irregularities, and hormonal imbalance-related symptoms in women of reproductive age.
This medication should only be used under medical supervision. It is contraindicated in women with a history of thromboembolic disorders, liver disease, breast cancer, or uncontrolled hypertension. Smoking increases the risk of cardiovascular side effects, especially in women over 35. Not intended for use during pregnancy.
Store at room temperature (15-30°C), away from direct sunlight and moisture. Keep out of reach of children.
Composition : Lactulose 15 ml contains lactulose concentrate 66.7% in 6 gm Syrup
Composition : Ayurvedic Constipation Syrup
Composition : Aceclofenac (200mg) + Rabeprazole (20mg) Capsule
Composition : Acotiamide (100mg) Tablet
Composition : Acotiamide (300mg) Tablet
Composition : Magaldrate I.P. 400mg + Simethicone I.P. 20mg (Mango & Mint Flavour)
Composition : Magaldrate I.P. 480mg + Simethicone I.P. 20mg + Oxetacaine B.P. 10mg
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This oral contraceptive combination has strong demand in the gynecology segment, making it a widely prescribed product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in oral contraception, menstrual regulation, acne associated with hormonal imbalance, and polycystic ovary syndrome (PCOS) management support. It is widely prescribed by gynecologists for both contraceptive and hormonal regulation purposes.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Drospirenone 3mg + Ethinylestradiol 0.02mg Tablet with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady monthly prescription demand, long-term contraceptive use cycles, and strong acceptance in gynecology and women’s health markets when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this gynecology formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.